Literature DB >> 26340382

Single-level lumbar pyogenic spondylodiscitis treated with mini-open anterior debridement and fusion in combination with posterior percutaneous fixation via a modified anterior lumbar interbody fusion approach.

Yang Lin1, Feng Li1, Wenjian Chen1, Heng Zeng1, Anmin Chen1, Wei Xiong1.   

Abstract

OBJECT: This study evaluated the efficacy and safety of mini-open anterior debridement and lumbar interbody fusion in combination with posterior percutaneous fixation for single-level lumbar pyogenic spondylodiscitis.
METHODS: This is a retrospective study. Twenty-two patients with single-level lumbar pyogenic spondylodiscitis underwent mini-open anterior debridement and lumbar interbody fusion in combination with posterior percutaneous fixation via a modified anterior lumbar interbody fusion (ALIF) approach. Patients underwent follow-up for 24 to 38 months. Clinical data, etiological examinations, operative time, intraoperative blood loss, American Spinal Injury Association (ASIA) grade, Japanese Orthopaedic Association (JOA) lumbar function score, visual analog scale (VAS) score, Oswestry Disability Index (ODI), postoperative complications, and the bony fusion rate were recorded.
RESULTS: The mean operative time was 181.1 ± 22.6 minutes (range 155-240 minutes). The mean intraoperative blood loss was 173.2 ± 70.1 ml (range 100-400 ml). Infection was found in lumbar vertebrae L2-3, L3-4, and L4-5 in 2, 6, and 14 patients, respectively. Bacterial cultures were positive in 15 patients, including 4 with Staphylococcus aureus, 6 with Staphylococcus epidermidis, 4 with Streptococcus, and 1 with Escherichia coli. Postoperative complications included urinary retention, constipation, and numbness in the thigh in 5, 3, and 2 patients, respectively. Compared with before surgery, the VAS scores and ODI were significantly lower at the final follow-up, the JOA scores were significantly higher, and the ASIA grades had improved. All patients achieved good intervertebral bony fusion.
CONCLUSIONS: Mini-open anterior debridement and lumbar interbody fusion in combination with posterior percutaneous fixation via a modified ALIF approach results in little surgical trauma and intraoperative blood loss, acceptable postoperative complications, and is effective and safe for the treatment of single-level lumbar pyogenic spondylodiscitis. This approach could be an alternative to the conventional open surgery.

Entities:  

Keywords:  ALIF = anterior lumbar interbody fusion; ASIA = American Spinal Injury Association; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; JOA = Japanese Orthopaedic Association; ODI = Oswestry disability index; VAS = visual analog scale; WBC = white blood cell count; anterior lumbar interbody fusion; complication; curative effect; infection; lumbar pyogenic spondylodiscitis; mini-open; percutaneous fixation

Mesh:

Year:  2015        PMID: 26340382     DOI: 10.3171/2015.5.SPINE14876

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  15 in total

1.  Pyogenic lumbar spondylodiscitis treated with transforaminal lumbar interbody fusion: safety and outcomes.

Authors:  Ajoy Prasad Shetty; Siddharth N Aiyer; Rishi Mugesh Kanna; Anupama Maheswaran; Shanmuganathan Rajasekaran
Journal:  Int Orthop       Date:  2015-12-28       Impact factor: 3.075

2.  Short lever arm, bipedicular handlebar construct for correction of acute angular kyphosis in spondylodiscitis-induced kyphotic deformity: illustrative case.

Authors:  Meng Huang; Iahn Cajigas; Steven Vanni
Journal:  J Neurosurg Case Lessons       Date:  2021-06-14

Review 3.  Management of spinal infection: a review of the literature.

Authors:  Sara Lener; Sebastian Hartmann; Giuseppe M V Barbagallo; Francesco Certo; Claudius Thomé; Anja Tschugg
Journal:  Acta Neurochir (Wien)       Date:  2018-01-22       Impact factor: 2.216

4.  Transplantation of Hypoxic-Preconditioned Bone Mesenchymal Stem Cells Retards Intervertebral Disc Degeneration via Enhancing Implanted Cell Survival and Migration in Rats.

Authors:  Weiheng Wang; Yang Wang; Guoying Deng; Jun Ma; Xiaodong Huang; Jiangming Yu; Yanhai Xi; Xiaojian Ye
Journal:  Stem Cells Int       Date:  2018-02-14       Impact factor: 5.443

5.  Transplantation of allogenic nucleus pulposus cells attenuates intervertebral disc degeneration by inhibiting apoptosis and increasing migration.

Authors:  Weiheng Wang; Guoying Deng; Yuanyuan Qiu; Xiaodong Huang; Yanhai Xi; Jiangming Yu; Xiangqun Yang; Xiaojian Ye
Journal:  Int J Mol Med       Date:  2018-02-02       Impact factor: 4.101

6.  Presentation and Outcomes After Medical and Surgical Treatment Versus Medical Treatment Alone of Spontaneous Infectious Spondylodiscitis: A Systematic Literature Review and Meta-Analysis.

Authors:  Davis G Taylor; Avery L Buchholz; Durga R Sure; Thomas J Buell; James H Nguyen; Ching-Jen Chen; Joshua M Diamond; Perry A Washburn; James Harrop; Christopher I Shaffrey; Justin S Smith
Journal:  Global Spine J       Date:  2018-12-13

7.  One-stage Debridement via Oblique Lateral Interbody Fusion Corridor Combined with Posterior Pedicle Screw Fixation in Treating Spontaneous Lumbar Infectious Spondylodiscitis: A Case Series.

Authors:  Yong-Jun Tong; Jun-Hui Liu; Shun-Wu Fan; Feng-Dong Zhao
Journal:  Orthop Surg       Date:  2019-11-07       Impact factor: 2.071

8.  Minimally Invasive Surgery Oblique Lumbar Interbody Debridement and Fusion for the Treatment of Lumbar Spondylodiscitis.

Authors:  Bingjin Wang; Chao Chen; Wenbin Hua; Wencan Ke; Saideng Lu; Yukun Zhang; Xianlin Zeng; Cao Yang
Journal:  Orthop Surg       Date:  2020-06-10       Impact factor: 2.071

9.  A rare lumbar pyogenic spondylodiscitis caused by staphylococcus caprae with initial misdiagnosis: case report and literature review.

Authors:  Zihan Fan; Yong Yang; Dong Li; Qi Fei
Journal:  BMC Surg       Date:  2020-09-14       Impact factor: 2.102

10.  Application of polyetheretherketone cages through minimally invasive oblique retroperitoneal approach for the treatment of lumbar polymicrobial spondylodiscitis: A STROBE-compliant retrospective study with 7 cases.

Authors:  Wei Luo; Yong Zhu; Zeng-Hui Zhao; Yun-Sheng Ou
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.